Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 4—April 2008

Research

Control Measures Used during Lymphogranuloma Venereum Outbreak, Europe

Aura Timen*†Comments to Author , Marlies E.J.L. Hulscher‡, Dieuwke Vos*†, Marita J.W. van de Laar*§, Kevin A. Fenton¶, Jim E. Van Steenbergen*, Jos W.M. van der Meer‡, and Richard P.T.M. Grol‡
Author affiliations: *National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; †Dutch Association for Public Health Services, Utrecht, the Netherlands; ‡University Medical Centre, St. Radboud, Nijmegen, the Netherlands; §European Centre for Disease Prevention and Control, Stockholm, Sweden; ¶Health Protection Agency, London, UK;

Main Article

Table 2

Implementation of control measures used by 18 European countries during an LGV outbreak*

Implementation measure All countries 
(n = 18) Countries with cases (n = 11)
Disseminating educational materials 9 8
Conferences for professionals 3 3
National bulletins 5 4
Outreach visits 0 0
Computer reminders 0 0
Changes in medical records systems 0 0
Changes in facilities and equipment 0 0
Additional finances 3 3
Strategy for media communication
6
5
Involvement of MSM society in dissemination of information
11
8
Targets to monitor effectiveness 0 0

*Data gathered through a survey. LGV, lymphogranuloma venereum; STI, sexually transmitted infection; MSM, men who have sex with men.
†Data were missing for 3 countries for this category.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO